CClinicalTrials.gg
Not yet recruitingNCT07803224Updated Sep 3, 2026

Adult ADHD Symptoms, Depression, Anxiety, and Academic Performance in Medical Students

An observational study in Attention Deficit Hyperactivity Disorder, Depression and Anxiety, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-03.

Sponsored by Assiut University · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
52
Ages
18 Years and older
Sex
All
01

Study summary

Attention-deficit/hyperactivity disorder (ADHD) is increasingly recognized to persist into adulthood, often impacting academic performance in university and professional education. This relationship may be further complicated by co-occurring mental health conditions, such as depression and anxiety.

The purpose of this cross-sectional study is to determine the prevalence of adult ADHD symptoms, depressive symptoms, and anxiety symptoms among undergraduate medical students at Assiut University. The study also aims to evaluate how these psychiatric symptoms are associated with academic performance.

Participants will complete a series of self-administered questionnaires, including the Adult ADHD Self-Report Scale (ASRS v1.1), the Patient Health Questionnaire-9 (PHQ-9) for depression, the Generalized Anxiety Disorder-7 (GAD-7) scale for anxiety, a socioeconomic status scale, and demographic/academic information including cumulative grade point average (GPA).

02

Conditions studied

  • Attention Deficit Hyperactivity Disorder
  • Depression
  • Anxiety
  • Academic Performance

Keywords

  • Adult ADHD
  • Medical Students
  • Academic Performance
  • ASRS v1.1
  • PHQ-9
  • GAD-7
  • Depressive Symptoms
  • Anxiety Symptoms
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

The study population consists of undergraduate medical students aged 18 years or older who are currently enrolled at the Faculty of Medicine, Assiut University, Egypt.

Inclusion criteria

  • Undergraduate students enrolled at the Faculty of Medicine, Assiut University
  • Aged 18 years or older
  • Willing to participate and provide electronic informed consent
  • Able to complete the study questionnaire

Exclusion criteria

Exclusion Criteria:

  • Postgraduate students or students enrolled in other faculties
  • Substantially incomplete questionnaires (missing essential demographic data, academic indicators, or screening scale items)
  • Refusal to participate
04

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
52 participants (estimated)
Patient registry
No

Groups and cohorts

  • Undergraduate Medical Students

    Undergraduate medical students aged 18 years or older enrolled at the Faculty of Medicine, Assiut University, who complete self-administered questionnaires assessing adult ADHD symptoms (ASRS v1.1), depressive symptoms (PHQ-9), anxiety symptoms (GAD-7), socioeconomic status, and academic performance (cumulative GPA).

05

What researchers measure

Primary outcomes

  1. Percentage of Participants Screening Positive for Adult ADHD Symptoms

    Assessed using the 6-item Adult ADHD Self-Report Scale (ASRS v1.1) Arabic version. The scale evaluates the frequency of inattention and hyperactivity/impulsivity symptoms over the preceding 6 months. Each item is rated on a 5-point scale (never, rarely, sometimes, often, very often). A positive screen is defined by meeting the established clinical cutoff threshold (responses falling within shaded/clinically significant boxes), indicating a high likelihood of adult ADHD symptoms.

    Time frame: Baseline

06

Study locations

No study locations are listed for this record.

07

Registry details

Key details

Study ID
NCT07803224
Lead sponsor
Assiut University
Responsible party
Ibrahim Mostafa Ahmed Ibrahim (Resident of Neurology and Psychiatry, Assiut University) — Principal investigator
First posted
Sep 3, 2026
Start date
Oct 2026 (estimated)
Primary completion
Oct 2027 (estimated)
Completion
Nov 2027 (estimated)
Last update
Sep 3, 2026
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion